DERMAZINC- pyrithione zinc spray

DermaZinc by

Drug Labeling and Warnings

DermaZinc by is a Otc medication manufactured, distributed, or labeled by WynnPharm Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Pyrithione Zinc 0.25%

KEEP OUT OF REACH OF CHILDREN

Keep Out of Reach of Children.

PURPOSE

Anti-dandruff

Seborrheic Dermatitis treatment

DOSAGE & ADMINISTRATION

Apply to affected areas twice daily or as directed by a doctor.

INDICATIONS & USAGE

For relief of the symptoms of seborrheic dermatitis and dandruff.

WARNINGS

Warnings
■ For external use only.
■ Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this
product as directed.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

INACTIVE INGREDIENT

Isopropyl Myristate, SD-Alcohol 40-B, Sodium Lauryl Sulfate, Undecylinic Acid

PRINCIPAL DISPLAY PANEL

Inner/Immediate Label

INGREDIENTS AND APPEARANCE

DERMAZINC 
pyrithione zinc spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 35324-002
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5)	PYRITHIONE ZINC	0.25 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
UNDECYLENIC ACID (UNII: K3D86KJ24N)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
ALCOHOL (UNII: 3K9958V90M)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 35324-002-04	1 in 1 BOX	08/29/2022
1		120 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M032	08/29/2022

Labeler - WynnPharm Inc (620885173)

Registrant - WynnPharm Inc (620885173)